---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-031051"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2023-08-31T23:59:59+00:00"
generated_at: "2026-06-11T01:18:13.184018+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics shareholders elect directors, approve executive pay, ratify auditor at annual meeting

## Summary
- Elected Dwight Egan (6,103,488 for) and Eugene Durenard (4,017,019 for) as Class II directors for three-year terms.
- Advisory vote on executive compensation approved: 6,426,011 for, 1,221,093 against, 236,466 abstain.
- Ratified Tanner LLC as independent auditor for 2023: 14,966,948 for, 334,913 against, 393,098 abstain.
- Broker non-votes were 7,811,389 on director election and executive compensation proposals.

## SEC filing metadata
- accession: 0001493152-23-031051
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2023-08-31T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315223031051/0001493152-23-031051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315223031051/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-031051
- JSON: https://secwatch.observer/filing/0001493152-23-031051.json
- Plain text: https://secwatch.observer/filing/0001493152-23-031051.txt

## Key facts
- Shareholder Votes
  Co-Diagnostics, Inc. shareholders approved Adoption, on an advisory basis, of a non-binding resolution approving the compensation of the Company's named executive officers. at the 2023-08-30 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-08-30
  source text: Proposal No. 2 : A proposal to adopt, on an advisory basis, a non-binding resolution approving the compensation of the Company’s named executive officers, as described in the Proxy Statement under “Executive Compensation.” This proposal was adopted.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1692415/000149315223031051/0001493152-23-031051-index.htm
- Shareholder Votes
  Co-Diagnostics, Inc. shareholders approved Election of two Class II directors to hold office for a term expiring at the annual meeting of stockholders to be held in 2026 or until their respective successors are elected and qualified. at the 2023-08-30 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-08-30
  source text: Proposal No. 1 : A proposal to elect two Class II directors to hold office for a term expiring at the annual meeting of stockholders to be held in 2026 or until their respective successors are elected and qualified. This proposal was approved and Messrs. Egan and Durenard were elected to the board of directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1692415/000149315223031051/0001493152-23-031051-index.htm
- Shareholder Votes
  Co-Diagnostics, Inc. shareholders approved Ratification of the Audit Committee's appointment of Tanner LLC as the Company's independent registered public accounting firm for the year ending December 31, 2023. at the 2023-08-30 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-08-30
  source text: Proposal No. 3 : A proposal to ratify the Audit Committee’s appointment of Tanner LLC as the Company’s independent registered public accounting firm for the year ending December 31, 2023. This proposal was ratified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1692415/000149315223031051/0001493152-23-031051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.